Who
Srini Tenjarla
SVP, CMC & Formulation
Company insider
Files Form 4 as: SVP, CMC & Formulation, Serina Therapeutics.
In numbers
- Trades disclosed
- 5
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 15 Jul 2024
- Last trade
- 21 May 2026
- Last filed
- 26 May 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 21 May 2026filed 26 May 2026 | SER Serina Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —85,558 at $0.00 | filing |
| 21 May 2026filed 26 May 2026 | SER Serina Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —85,558 at $0.00 | filing |
| 3 Feb 2026filed 17 Feb 2026 | SER Serina Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —69,000 at $0.00 | filing |
| 3 Feb 2026filed 17 Feb 2026 | SER Serina Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —69,000 at $0.00 | filing |
| 15 Jul 2024filed 17 Jul 2024 | SER Serina Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —185,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.